UCAR T-cell Therapy Targeting CD19/ BCMA in Patients With Relapse/ Refractory Autoimmune Diseases

Clinical trial NCT06978738 · NOT_YET_RECRUITING

Trial details

NCT number: NCT06978738
Sponsor: Changzhou No.2 People's Hospital
Status: NOT_YET_RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Systemic Lupus Erythematosus Autoimmune Hemolytic Anemia Myasthenia Gravis Systemic Sclerosis ANCA-Associated Vasculitis Inflammatory Myopathy IgG4-RD

Start date: 2025-05-01
Primary completion: 2027-05-01
Enrollment: 18

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.